{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/03/27/3263679/0/en/Editas-Medicine-Announces-U-S-Patent-and-Trademark-Office-Reaffirms-its-Prior-Decision-in-Favor-of-the-Broad-Institute-in-CRISPR-Cas9-Interference.html", "message": "News view counter 628677 successfully enlarged"}